November 3, 2016
More than a year after a breakthrough drug for cystic fibrosis became available, fewer than half of patients who meet the Food and Drug Administration’s criteria can actually access the medication.
September 23, 2016
Medicine is at a crossroads; cardiology in particular. I saw this fact magnified at the American Society for Preventive Cardiology’s recent town hall on access barriers to PCSK9 inhibitors.
July 22, 2016
Patients with Alzhe.imer’s or Parkinson’s disease may have a new source of hope: cancer drugs
July 20, 2016
July 12 and 13 hearings of the FDA’s Arthritis Advisory Committee cleared the way for two new biosimilars, adalimumab and etanercept. The committee unanimously supported manufacturers’ applications for the drugs – but that wasn’t the only point of consensus. Participants and even committee members expressed concerns about unfinished regulatory policy and the need to prioritize patient safety.
July 12, 2016
Breathing complications aren’t the only challenge faced by the 26 million Americans with asthma, explains a new video from the Alliance for Patient Access.
June 21, 2016
Stakeholders are divided over a provision of the Food and Drug Administration’s draft regulatory guidance on biosimilar labeling, letters to the FDA reveal.
June 7, 2016
Vice President Joe Biden addressed oncologists, industry and medical professionals in Chicago Monday with a resounding plea: collaborate to “translate scientific discovery into meaningful treatments.”
May 26, 2016
A movement to make cancer treatment more personalized, more targeted and more effective has real potential for patients – but only if they can access the needed diagnostics and medications.
May 24, 2016
Three months after President Barack Obama requested congressional funding to fight the Zika virus, the House of Representatives has authorized $622 million in aid. But will congressional funding be too little, too late for those fighting Zika?
May 1, 2016
Treatments for cancer have improved dramatically in recent decades. The five-year survival rate – the percentage of people with cancer…